Status:
COMPLETED
Use of a Point-of-Care Platelet Function Assay for the Prediction of Atherothrombotic Events
Lead Sponsor:
CardioVascular Research Foundation, Korea
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
1. To evaluate the role of VerifyNow test as prognostic marker in routine clinical practice using drug-eluting stents. 2. To determine the add-on-effect of VerifyNow test beyond on conventional risk f...
Detailed Description
Predictive role of a point-of-care assay (VerifyNow test) has not been well evaluated in large number of patients receiving drug-eluting stents as a routine practice. In addition, additional predicti...
Eligibility Criteria
Inclusion
- Consecutive patients with established coronary artery disease receiving PCI with stent implantation
Exclusion
- Cardiogenic shock
- Patients using concomitant medication known to affect platelet function other than aspirin (i.e. nonsteroidal antiinflammatory agents, dipyramidole, upstream glycoprotein IIb/IIIa inhibitors)
- patients with a known platelet function disorder or a whole blood platelet count of less than 150000/μL.
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT01183754
Start Date
March 1 2006
End Date
December 1 2010
Last Update
February 1 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea